Ultrasound-guided intralesional bleomycin injection (IBI ...
Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism...
-
Upload
cuthbert-robertson -
Category
Documents
-
view
226 -
download
2
Transcript of Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism...
![Page 1: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/1.jpg)
Bleomycin
Catalina Cuervo
![Page 2: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/2.jpg)
Outline of Topics
• Introduction to Bleomycin• Structure• Mechanism• Resistance• Analogs• Conclusion
![Page 3: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/3.jpg)
Bleomycin • Phleomycin was discovered in 1956 by
Hamao Umezawa• Exhibited inhibition of Ehrlich carcinoma
with high therapeutic index but showed renal toxicity in dogs
• During a search for antibiotics of similar type, Bleomycin (BLM) was discovered
• Bleomycin showed reversible heptatotoxicity, but no renal toxicity
![Page 4: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/4.jpg)
• BLMs are glycopeptide antibiotics isolated from streptomyces verticillus
• They are used as a chemotherapeutic agent to treat primarily head and neck cancer,testicular cancer, and lymphomas
• BLMs interacts with DNA and induce damage
• BLMs chelate iron and combine with oxygen molecules to form the active form
![Page 5: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/5.jpg)
Side effects:
• 1% patients-BLM induced pulmonary fibrosis and die
• 1% lymphoma patients-idiosyncratic reaction (confusion, fever, chills, and wheezing)
• 10% patients-pneumonitis• 50% patients develop other side effects
including rash and tenderness of skin
![Page 6: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/6.jpg)
• Treatment is discontinued in 2% of patients because of side effects
• Because of allergic reactions in some lymphoma patients, a very small dose is administered (1-2 units)
• Normal dose ranges from 0.25 unit per kilogram of body mass twice a week to 1 unit daily
![Page 7: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/7.jpg)
Structure
• BLMs have the same backbone• They differ by their terminal amine• The mixture of BLMs that is used
clinically is A2 (55-70%) and B2 (25-32%)
![Page 8: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/8.jpg)
![Page 9: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/9.jpg)
Structure is separated into three domains:
1.Metal-binding domain:ß-aminoalaninamide, pyrimidine,ß-hydroxyhistidine-Responsible for formation of the complex with Fe(II)
2.DNA binding domain: bithiazole ring system and terminal amine substituent
![Page 10: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/10.jpg)
3.Carbohydrate moiety: aids in membrane permeability and recognizes tumor cells
![Page 11: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/11.jpg)
![Page 12: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/12.jpg)
Metal Complex
• BLMs can form metal complexes with Fe, Cu, Co, Zn, Mn
• For therapeutic effects the Fe-BLM complex is used
![Page 13: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/13.jpg)
Cycle of Events: Activation of Bleomycin
![Page 14: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/14.jpg)
Activation of Bleomycin Complex
![Page 15: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/15.jpg)
Binding of BLM to DNA
• The minor groove of the DNA helix is the binding site for BLM
• Active BLMs bind to guanine bases in DNA through the bithiazole unit
![Page 16: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/16.jpg)
Mechanism
• Two mechanisms account for DNA strand scission
• Differences between mechanisms: products formed and amount of oxygen needed
![Page 17: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/17.jpg)
Mechanism 1
![Page 18: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/18.jpg)
Mechanism 2
![Page 19: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/19.jpg)
• Strand scission mediated by Bleomycin is sequence selective
• 5‘-GT-3‘ and 5‘-GC-3‘• Always at the 3‘ side of G
![Page 20: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/20.jpg)
Resistance
• Resistance of cells to BLM is caused by an aminopeptidase (BLM hydrolase) that hydrolyses the carboxamide group of the L-aminoalaninecarboxamide substituent in the antibiotic that does not contain the metal
![Page 21: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/21.jpg)
Analogs
• The major problems with Bleomycin stem from the drug’s cytotoxicity
• Liblomycin and Victomycin are succeeding Bleomycin because they exhibit milder cytotoxicity
![Page 22: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/22.jpg)
Conclusion
• Bleomycins are antitumor agents• Glycopeptides with the same
backbone but differ in the structure of their terminal amine
• Cause DNA breakage, a process that requires oxygen and Fe(II)
![Page 23: Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.](https://reader035.fdocuments.us/reader035/viewer/2022062308/56649e615503460f94b5ca72/html5/thumbnails/23.jpg)